Worldwide Immuno Oncology Assays Industry to 2026 - Clinical Trials to Cure Different Cancers in Immunotherapy Presents Opportunities
05 janv. 2022 06h38 HE
|
Research and Markets
Dublin, Jan. 05, 2022 (GLOBE NEWSWIRE) -- The "Immuno Oncology Assays Market Research Report by Indication, Product, Technology, Application, and Region - Global Forecast to 2026 - Cumulative Impact...
Tyrokinse Kinase Inhibitors in the Global Oncology Market 2021: Market Leaders by Indication and Product
05 nov. 2021 05h58 HE
|
Research and Markets
Dublin, Nov. 05, 2021 (GLOBE NEWSWIRE) -- The "Oncology Markets for Tyrokinse Kinase Inhibitors" report has been added to ResearchAndMarkets.com's offering. Traditional cancer therapy has focused...
NEW AAD SURVEY: Only a Third of Americans are Concerned About Skin Cancer Despite Nearly 70% Having at Least One Risk Factor
15 juin 2021 14h30 HE
|
American Academy of Dermatology
ROSEMONT, Ill., June 15, 2021 (GLOBE NEWSWIRE) -- With the first day of summer right around the corner, many Americans will increasingly head to the beach or water parks to cool down, but will they...
Sorrento Announces Clinical Research Agreement With Mayo Clinic and FDA Clearance for the First Phase 1b Pilot Study Using Sofusa Lymphatic Drug Delivery Technology to Deliver Ipilimumab in Patients With Melanoma
11 juin 2021 09h00 HE
|
Sorrento Therapeutics, Inc.
SAN DIEGO, June 11, 2021 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento") today announced a research collaboration agreement with Mayo Clinic to conduct human clinical...
Confused About Sunscreen? New American Academy of Dermatology Survey Shows Americans Need a Refresher on Sunscreen Application and SPF
25 mai 2021 14h00 HE
|
American Academy of Dermatology
ROSEMONT, Ill., May 25, 2021 (GLOBE NEWSWIRE) -- With many planning outdoor gatherings this Memorial Day weekend, board-certified dermatologists want to make sure consumers don’t get burned by...
MacroGenics Announces Preliminary Clinical Results from Phase 1 Study of MGC018 to be Presented at ASCO Annual Meeting
19 mai 2021 17h05 HE
|
MacroGenics, Inc.
Dose escalation: anti-tumor activity observed in melanoma (including one confirmed partial response) and in mCRPC patientsCohort expansion in mCRPC: 11/22 (50%) patients have ≥ 50% PSA reduction;...
Global Immuno-Oncology Assays Market (2021 to 2026) - Growing Significance of Companion Diagnostics Presents Opportunities
14 mai 2021 05h23 HE
|
Research and Markets
Dublin, May 14, 2021 (GLOBE NEWSWIRE) -- The "Immuno-Oncology Assays Market by Product & Service (Consumables, Instruments, Software), Technology (PCR, NGS, Immunoassay), Cancer Indications...
How to Check Your Nails for Melanoma; American Academy of Dermatology
11 mai 2021 14h00 HE
|
American Academy of Dermatology
ROSEMONT, Ill., May 11, 2021 (GLOBE NEWSWIRE) -- When checking the body for signs of skin cancer, many people may only think to check their skin. However, board-certified dermatologists from the...
New American Academy of Dermatology Survey Finds One-Third of Americans Fail Basic Quiz on Skin Cancer and Sun Exposure
27 avr. 2021 14h52 HE
|
American Academy of Dermatology
ROSEMONT, Ill., April 27, 2021 (GLOBE NEWSWIRE) -- In a recent survey of 1,000 U.S. adults, the American Academy of Dermatology found that one-third of Americans lack a basic understanding of skin...
Global Immuno-Oncology Market Report 2021-2026: Merck's Keytruda (Pembrolizumab) Leads the Market
29 mars 2021 06h53 HE
|
Research and Markets
Dublin, March 29, 2021 (GLOBE NEWSWIRE) -- The "Immuno-Oncology - Market Analysis, Trends, Opportunities and Unmet Needs - Thematic Research" report has been added to ResearchAndMarkets.com's...